Status:
COMPLETED
Microcirculation in Cardiogenic Shock
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Cardiogenic Shock
Eligibility:
All Genders
18+ years
Brief Summary
Cardiogenic shock is usually defined as primary cardiac dysfunction with low cardiac output leading to critical organ hypo perfusion and tissue hypoxia. Despite progress in the management of cardiogen...
Eligibility Criteria
Inclusion
- major patient (≥18 years old)
- Patient with a cardiogenic shock table defined by the association of low cardiac output even though the filling pressures are normal or high, causing hypoperfusion and organ pain
- patient affiliated to a social security scheme
- patient (or family member / trusted or close) who has agreed to participate in the study
Exclusion
- refusal of the patient to participate in the study
- patients with dark skin preventing the evaluation of clinical markers of microcirculation.
- subject under the protection of justice
- subject under guardianship or curatorship
Key Trial Info
Start Date :
September 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 30 2020
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT03436641
Start Date
September 1 2018
End Date
July 30 2020
Last Update
August 23 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Nancy - Hôpital Brabois
Nancy, France, 54511
2
Les Hôpitaux Universitaires de Strasbourg
Strasbourg, France, 67091